Drug intelligence / Profile preview

FL058 placebo + meropenem

Development stage
Unknown
Lead developer
Qilu Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

FL058 placebo + meropenem is a combination therapy consisting of a placebo (designated as "FL058") and the antibiotic meropenem. Meropenem is a broad-spectrum carbapenem antibiotic used to treat various serious bacterial infections, including complicated skin and skin structure infections, intra-abdominal infections, and bacterial meningitis in both adults and children. It works by inhibiting bacterial cell wall synthesis, leading to cell death. The "placebo" component (FL058) serves as an inactive comparator or control in clinical studies; it has no pharmacological effect.

Brand names
Merrem
Other names
meropenemMerrem Novaplus
02

Targets

NeuraminidasePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on FL058 placebo + meropenem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FL058 placebo + meropenem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call